erythromycin has been researched along with Duodenal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardou, M; Barkun, AN; Gralnek, IM; Martel, M; Sung, JJ | 1 |
| Daram, SR; Garretson, R | 1 |
1 review(s) available for erythromycin and Duodenal Diseases
| Article | Year |
|---|---|
Prokinetics in acute upper GI bleeding: a meta-analysis.
Topics: Acute Disease; Blood Transfusion; Duodenal Diseases; Endoscopy, Digestive System; Erythromycin; Esophageal Diseases; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Metoclopramide; Premedication; Randomized Controlled Trials as Topic; Stomach Diseases | 2010 |
1 other study(ies) available for erythromycin and Duodenal Diseases
| Article | Year |
|---|---|
Erythromycin is preferable to metoclopramide as a prokinetic in acute upper GI bleeding.
Topics: Duodenal Diseases; Endoscopy, Digestive System; Erythromycin; Esophageal Diseases; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Metoclopramide; Premedication; Stomach Diseases | 2011 |